Litao Liang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Health and Family Planning Commission, Peking Union Medical College Hospital, Jiangsu Province Hospital, Nanjing Medical University

发表论文 53 篇 · 总被引 593 次 · h-index 11

代表论文

• LRP11 facilitates lipid metabolism and malignancy in hepatocellular carcinoma by stabilizing RACK1 through USP5 regulation (2025 · Molecular Medicine · 被引 10)
• Hypoxia-induced RCOR2 promotes macrophage M2 polarization and CD8 + T-cell exhaustion by enhancing LIF transcription in hepatocellular carcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 7)
• Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis (2024 · Journal of Hepatocellular Carcinoma · 被引 7)
• Long Non-coding RNA 02298 Promotes the Malignancy of HCC by Targeting the miR-28-5p/CCDC6 Pathway (2024 · Biochemical Genetics · 被引 7)
• HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA (2024 · International Journal of Biological Sciences · 被引 7)
• Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target (2025 · Cancer Cell International · 被引 4)